NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit

Source :: GlobeNewswire. April 25, 2024
Publication Year :: 2024
Abstract: In vitro studies with SNK01 have shown a direct ability to phagocytose and digest amyloid and alpha-synuclein proteins while also secreting immunoregulatory cytokines and identifying and eliminating autoreactive T cells [...]

Subjects :: T cells -- Forecasts and trends
Autoimmunity -- Forecasts and trends
Biotechnology -- Forecasts and trends
Killer cells -- Forecasts and trends
Proteins -- Forecasts and trends
Alzheimer's disease -- Drug therapy
Antiparkinsonian agents -- Forecasts and trends
Market trend/market analysis
Banking, finance and accounting industries
Business

Tools